Lars B. Abrahmsen - SVP, Chief Scientific Officer at Aprea Therapeutics, Inc.

Issuer-level insider activity

Role
SVP, Chief Scientific Officer
Issuer ticker
APRE on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Lars B. Abrahmsen since 09 Aug 2025

Reported holdings for Lars B. Abrahmsen in Aprea Therapeutics, Inc.

Form 4 holding SVP, Chief Scientific Officer

Aprea Therapeutics, Inc.

Security class
Common Stock
Shares / value
43,700
Estimated value
$160,855
Report date
10 Mar 2022
Price
$3.68
Ownership
Direct
Form 4 holding SVP, Chief Scientific Officer

Aprea Therapeutics, Inc.

Security class
Stock Option (right to Buy)
Shares / value
100,000
Estimated value
Report date
10 Mar 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Lars B. Abrahmsen in Aprea Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .